tiprankstipranks
Achieve Life Sciences Inc (ACHV)
NASDAQ:ACHV

Achieve Life Sciences Financial Statements

913 Followers

Achieve Life Sciences Financial Overview

Achieve Life Sciences's market cap is currently ―. The company's EPS TTM is $-3.35; its P/E ratio is -1.49; Achieve Life Sciences is scheduled to report earnings on November 9, 2022, and the estimated EPS forecast is $-1.04. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -7.22M$ -7.12M$ -6.69M$ -11.30M$ -8.00M
EBITDA$ -7.16M$ -7.05M$ -6.63M$ -11.24M$ -7.93M
Net Income Common Stockholders$ -7.57M$ -7.15M$ -6.69M$ -11.31M$ -8.00M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 22.39M$ 29.64M$ 33.31M$ 35.85M$ 36.34M
Total Assets$ 40.61M$ 47.52M$ 37.80M$ 45.56M$ 33.66M
Total Debt$ 82.00K$ 108.00K$ 127.00K$ 146.00K$ 186.00K
Net Debt$ -22.31M$ -29.53M$ -33.19M$ -35.71M$ -36.15M
Total Liabilities$ 19.18M$ 19.47M$ 3.10M$ 4.71M$ 3.57M
Stockholders Equity$ 21.43M$ 25.68M$ 28.04M$ 30.09M$ 34.70M
Cash Flow
Free Cash Flow$ -6.78M$ -5.22M$ -8.69M$ -9.08M$ -6.45M
Operating Cash Flow$ -6.78M$ -5.22M$ -8.69M$ -9.08M$ -6.45M
Investing Cash Flow$ ―$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 95.00K$ 14.93M$ 8.00K$ 21.44M$ 236.00K
Currency in USD

Achieve Life Sciences Earnings and Revenue History


Achieve Life Sciences Debt to Assets


Achieve Life Sciences Cash Flow


Achieve Life Sciences Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis